Pharmacological manipulation of ultrasound induced defence behaviour in the rat

Rats exposed to aversive stimuli display species specific defence behaviour as part of their natural survival strategy. One component of this behaviour is the production of ultrasonic calls in the 20 to 27-kHz range, which are thought to serve a communicative role. The present study has examined the behavioural effects of exposing, rats to artificially generated ultrasound and the ability of three distinct pharmacological agents to modify this response. Single tone 20 kHz ultrasound exposure for 1 min produced intensity-related locomotor behaviour, characteristic of defence behaviour, which could be measured using a computer tracking system. This was significantly reduced by peripheral pretreatment with the benzodiazepine, diazepam (0.3 and 3.0 mg/kg IP). Pretreatment with the 5-HT agonist 1-(3-chlorophenyl) piperazine (mCPP) (0.5–2.0 mg/kg IP) produced a dose-related reduction in the ultrasound-induced response. Theα2 adrenoceptor antagonist, yohimbine (0.5–5.0 mg/kg IP), caused an increase in the response at the lower doses (2.0 and 5.0 mg/kg). The present findings suggest that defence behaviour in the rat can be artificially produced by 20 kHz ultrasound; this is sensitive to pharmacological manipulation and may offer a novel animal model of aversive behaviours that are associated with human panic.

[1]  D. Blanchard,et al.  Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety , 1993, Behavioural Brain Research.

[2]  S. Brudzyński,et al.  Behavioural responses of laboratory rats to playback of 22 kHz ultrasonic calls , 1995, Physiology & Behavior.

[3]  E. Bullitt.  Expression of C‐fos‐like protein as a marker for neuronal activity following noxious stimulation in the rat , 1990, The Journal of comparative neurology.

[4]  W. J. Smith.  The Study of Ultrasonic Communication , 1979 .

[5]  S. Handley,et al.  Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  G. Sales.  The effect of 22 kHz calls and artificial 38 kHz signals on activity in rats , 1991, Behavioural Processes.

[7]  D. C. Blanchard,et al.  Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems , 1991, Physiology & Behavior.

[8]  Computer analysis and quantification of periaqueductal grey-induced defence behaviour , 1995, Journal of Neuroscience Methods.

[9]  R. Suckow,et al.  Trazodone and m-chlorophenylpiperazine Concentration in brain and receptor activity in regions in the brain associated with anxiety , 1985, Neuropharmacology.

[10]  T. Insel,et al.  Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists , 2005, Psychopharmacology.

[11]  J. Kehne,et al.  Serotonin receptor subtype agonists: differential effects on sensorimotor reactivity measured with acoustic startle. , 1986, Psychopharmacology bulletin.

[12]  C. R. Gardner.  Inhibition of ultrasonic distress vocalizations in rat pups by chlordiazepoxide and diazepam , 1985 .

[13]  R. Bandler,et al.  Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. , 1991, Progress in brain research.

[14]  C. Gardner.  Distress vocalization in rat pups. A simple screening method for anxiolytic drugs. , 1985, Journal of pharmacological methods.

[15]  G. Kennett,et al.  Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. , 1989, European journal of pharmacology.

[16]  C. Gardner,et al.  Pharmacological characterisation of a modified social interaction model of anxiety in the rat. , 1985, Neuropsychobiology.

[17]  K. Miczek,et al.  Diazepam and gepirone selectively attenuate either 20–32 or 32–64 kHz ultrasonic vocalizations during aggressive encounters , 2005, Psychopharmacology.

[18]  S. Southwick,et al.  Noradrenergic function in panic disorder. , 1990, The Journal of clinical psychiatry.

[19]  J. Nyby,et al.  Ultrasonic communication of adult myomorph rodents , 1978, Neuroscience & Biobehavioral Reviews.

[20]  D. Blanchard,et al.  Sex differences in the incidence and sonographic characteristics of antipredator ultrasonic cries in the laboratory rat (Rattus norvegicus). , 1992, Journal of comparative psychology.

[21]  W. Redfern,et al.  A search for brain stem cell groups integrating the defence reaction in the rat. , 1986, The Journal of physiology.

[22]  A. Frazer,et al.  Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex. , 1984, The Journal of pharmacology and experimental therapeutics.

[23]  J. Deakin,et al.  5-HT and mechanisms of defence , 1991, Journal of psychopharmacology.

[24]  M. Mattila,et al.  Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. , 1988, International clinical psychopharmacology.

[25]  R. J. Barfield,et al.  Ultrasonic vocalization of the female rat (Rattus norvegicus) during mating , 1985, Animal Behaviour.

[26]  K. Miczek,et al.  Ultrasounds during morphine withdrawal in rats , 2005, Psychopharmacology.

[27]  F. Graeff,et al.  Role of the amygdala and periaqueductal gray in anxiety and panic , 1993, Behavioural Brain Research.

[28]  B. Scatton,et al.  Antidopaminergic properties of yohimbine. , 1980, The Journal of pharmacology and experimental therapeutics.

[29]  Charles A. Marsden,et al.  Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray , 2005, Psychopharmacology.

[30]  S. File,et al.  Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. , 1987, Neuropsychobiology.

[31]  R. Mathew,et al.  Catecholamines and anxiety , 1982, Acta psychiatrica Scandinavica.

[32]  E. Rouiller,et al.  Mapping of c-fos expression elicited by pure tones stimulation in the auditory pathways of the rat, with emphasis on the cochlear nucleus , 1992, Neuroscience Letters.

[33]  C. Broekkamp,et al.  5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats , 2005, Psychopharmacology.

[34]  K. Lloyd,et al.  Enhancing GABAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region , 1982, Brain Research.

[35]  D. Charney,et al.  Monoamine receptor systems and anxiety disorders. , 1988, The Psychiatric clinics of North America.

[36]  T. Insel,et al.  Rat pup ultrasonic isolation calls: Possible mediation by the benzodiazepine receptor complex , 1986, Pharmacology Biochemistry and Behavior.

[37]  Gillian Sales,et al.  Ultrasound and mating behaviour in rodents with some observations on other behavioural situations , 2009 .

[38]  Michael Davis,et al.  Noradrenergic agonists and antagonists: Effects on conditioned fear as measured by the potentiated startle paradigm , 1979, Psychopharmacology.

[39]  L. Dwoskin,et al.  Evidence for antiserotonergic properties of yohimbine , 1988, Pharmacology Biochemistry and Behavior.

[40]  C. Broekkamp,et al.  Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion. , 1989, European journal of pharmacology.

[41]  M. Blumberg,et al.  Ultrasonic vocalizations by rat pups in the cold: an acoustic by-product of laryngeal braking? , 1990, Behavioral neuroscience.

[42]  F. Graeff.  The anti-aversive action of minor tranquillizers , 1984 .